What question would you ask a rep who consistently loses deals at the proposal stage to diagnose the real issue?
Ask the rep one question that forces them to expose the gap in their own discovery:
> "If you could rewind to the first meeting with this prospect, what one thing—about their budget, their decision process, or the alternatives they were weighing—would you make sure you knew before you ever wrote the proposal?"
A rep who loses repeatedly at the proposal stage almost never lost on the document. They lost because they built a solution for a problem that wasn't budgeted, wasn't prioritized by the full buying group, or had already been solved another way—and the proposal is simply where that gap finally became visible. The question above makes the rep name the missing piece themselves, which tells you whether you're coaching a qualification problem, a buying-committee alignment problem, or a genuine price/timing problem. Those three require completely different fixes, so the diagnosis matters more than any single follow-up.
The RevOps Reality Behind Proposal Losses
B2B purchases now routinely involve large, distributed buying groups. Gartner's research puts a typical B2B buying committee in the range of 6 to 10+ stakeholders, and reports that the single most common outcome of a B2B purchase effort is "no decision"—the deal dies against the status quo, not a competitor. AI tools like Gong and Clari surface deal-risk signals automatically, but they can't retroactively fix a rep who never confirmed budget or never mapped the people who can say no. A proposal loss is rarely a surprise; it's the predictable downstream result of a discovery step that got skipped.
The Diagnostic Framework: Three Layers of Inquiry
Don't ask "What went wrong?"—that invites excuses. Work the gap in layers.
Layer 1: The Discovery Autopsy
Ask: "What budget range did the prospect actually confirm—and how do you know it was real and not a polite deflection?" If the answer is "they said it wasn't a problem" or "we assumed," the deal was likely dead on arrival. Clari can flag deals where budget was never documented, but the rep still owns the conversation.
Ask: "Who on the buying group did you speak with, and what did a 'win' look like for each of them personally?" If the rep can't name the economic buyer, the technical evaluator, and a real champion—and articulate what each one wanted—they wrote the proposal half-blind. Forrester's work on champion development is clear that an engaged internal champion materially improves close rates, but only when that champion is actively coaching the rep on internal politics.
Layer 2: The Competitive Picture
Ask: "What was the prospect's real alternative—and why did it look attractive to them?" If the rep says "they didn't mention competitors," they didn't ask. Gong Labs research consistently shows that stronger reps engage competitive positioning earlier in the cycle rather than at the proposal stage. The proposal is far too late to discover the buyer already owns a Salesforce-native tool that covers most of what you do—for no incremental cost.
Layer 3: The Buying-Process Mismatch
Ask: "What step in their procurement process comes after your proposal, and who owns it?" If the rep doesn't know, they handed the deal to Legal and Security with no preparation. McKinsey's research on the modern B2B buying process emphasizes how much late-stage friction—data residency, SOC 2 Type II, multi-year terms—now lives downstream of the proposal. Reps who don't map that step are surprised by it every time.
The Decision Tree for Diagnosis
The Feedback Loop for Improvement
Real-World Example: The $500K SaaS Deal That Died at Proposal
A mid-market SaaS rep lost a $500K ARR deal and blamed the pricing page. The diagnostic told a different story:
- Budget: never confirmed—the prospect's CFO had a hard cap well below the proposal number.
- Committee: the rep had only spoken to the VP of Sales and never met the CIO, who required a SOC 2 Type II report the vendor couldn't produce.
- Competition: the incumbent platform had quietly shipped the same feature into its core product at no extra cost.
- Process: the buyer required a 30-day proof of concept before any proposal could even be evaluated—and the rep didn't know it existed.
The fix wasn't a better proposal. It was rebuilding the rep's discovery discipline around MEDDPICC so none of those four gaps could recur unnoticed.
The Tools That Surface These Gaps
- Gong: use Deal Risk to flag proposals sent with no documented next step. Then ask the rep, *"Gong scored this deal low before you sent the proposal—what did you see that the model missed?"*
- Clari: watch forecast-category drift. A deal sliding from Commit to Best Case to Omitted within two weeks is a proposal-stage loss in motion. Ask, *"What signal did Clari catch that you didn't act on?"*
- Outreach: check whether the post-proposal follow-up was generic. Ask, *"Why did the champion and the skeptic get the same email?"*
The Highest-Leverage Follow-Up Questions
Once the layered diagnostic surfaces the gap, three sharper probes separate a real fix from a hopeful one.
The silent competitor. *"When the prospect passed, what did they say they were doing instead—another vendor, an internal build, or nothing?"* The most common proposal-stage "loss" is not a competitor at all; it's the buyer choosing to defer or work around the problem with what they already own. If the rep never asked *"What happens if you don't solve this in the next 90 days?"*, they never quantified the cost of inaction—and the proposal was competing against a zero-dollar option it could never beat. The fix is a standing alternatives audit in discovery: *"Who else are you evaluating, including doing nothing or building it yourselves?"*
The decision timeline. *"What date did the prospect commit to a decision, and how did you verify it with the full group rather than just your champion?"* Reps routinely accept an optimistic "we'll decide in two weeks" without pressure-testing it against budget gates, procurement, and legal review. When the proposal then sits for weeks, urgency decays and a new objection appears. The fix is a mutual action plan with a review meeting on the calendar *before* the proposal goes out: *"I'll send this on [date]—can we hold 45 minutes on [date + 5 business days] with the key stakeholders? If we can't book it now, this is going to drift."* A prospect who won't agree is giving the rep a clean disqualify-or-escalate signal.
The champion's hidden agenda. *"What did your champion personally risk by backing this—and how did you uncover it?"* A champion who says "I love this" can still refuse to spend political capital, especially if your solution displaces a tool another executive owns. If the rep only met supporters and never the likely detractors, the proposal rested on a fragile coalition. The negative-reverse probe—*"What would have to be true for you to NOT recommend us?"*—forces both rep and champion to map who could veto the deal and why, while there's still time to address it in the proposal itself.
FAQ
What if the rep says they had all the information they needed?
Probe deeper: *"What did the prospect say when you asked about their implementation timeline and the consequences of waiting?"* Reps often mistake surface-level answers for real qualification. The gap is usually that they never verified urgency or the cost of inaction—exactly the things that turn fatal at the proposal stage.
How can you tell if the loss was about price versus poor discovery?
Ask, *"Did you confirm the budget range before writing the proposal, or did you assume it?"* A rep who genuinely lost on price almost always failed to anchor the conversation on value or to surface the real budget ceiling first. Most "price" objections are a symptom of thin qualification, not a true price mismatch.
What question reveals whether the rep aligned with the buying committee?
Ask, *"Who did you speak with in the final decision group, and what did each of them say their top priority was?"* If the rep can't name at least three distinct stakeholders and their concerns, they likely built the proposal around one person's agenda—a leading cause of losses in multi-stakeholder deals.
How do you uncover whether the rep skipped competitive analysis?
Ask, *"What did you learn about the alternatives the prospect was weighing, and how did you position against them?"* A rep who can't describe the shortlist or their own differentiation probably submitted a generic proposal that never addressed the buyer's actual comparison criteria.
What question exposes a lack of urgency in the deal?
Ask, *"What specific event or deadline was driving a decision, and how did you confirm it with the prospect?"* If there's no concrete timeline or consequence of delay, the proposal almost certainly landed in the "nice-to-have" pile. Urgency is a qualification factor that makes or breaks late-stage momentum.
How can you tell if the rep failed to validate solution fit?
Ask, *"What did the prospect say when you asked them to describe how they'd measure success after rolling this out?"* A rep who never got the buyer to define success in their own words is guessing at the outcome—and guessing produces proposals that solve the wrong problem.
Bottom Line
The proposal stage is where weak discovery comes to die. Ask the rep one question that forces them to admit they didn't know something critical—budget, committee, competitor, or process—then use Gong, Clari, and MEDDPICC to turn that admission into a repeatable diagnosis loop. The proposal was never the problem; the missing qualification was.
Related on PULSE
- [How do you handle a prospect who says 'just send me a proposal' before you've presented any value?](/knowledge/cg0906)
- [Top 10 Questions to Diagnose Why a Deal Stalled at the Negotiation Stage](/knowledge/cg0915)
- [What is the single most effective question to ask a salesperson who is consistently missing quota?](/knowledge/cg0811)
- [How do you coach a sales rep who's consistently missing quota?](/knowledge/cg0131)
- [How can I ask a question that helps a rep identify their own pattern of losing deals in the same stage?](/knowledge/cg0841)
- [What question would you ask during a pipeline review to force a rep to prioritize deals based on probability, not hope?](/knowledge/cg0902)
Sources
- Gong Labs: The Anatomy of a Won Deal
- Gartner: Win More B2B Sales Deals (Buying Groups)
- Forrester: The ROI of Champion Development
- McKinsey: The New B2B Buying Process
- SaaStr: How to Fix Underperforming Sales Reps
- Clari: Deal Risk Signals in the Age of AI
- MEDDICC / MEDDPICC: Command of the Message
*The real question isn't about the proposal—it's about the discovery that never happened.*










